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We have recently reported the ability of Leptospira to capture plasminogen (PLG) and generate plasmin (PLA) bound on the mi-
crobial surface in the presence of exogenous activators. In this work, we examined the effects of leptospiral PLG binding for ac-
tive penetration through the endothelial cell barrier and activation. The results indicate that leptospires with PLG association or
PLA activation have enhancedmigration activity through human umbilical vein endothelial cell (HUVEC) monolayers com-
pared with untreated bacteria. Leptospira cells coated with PLG were capable of stimulating the expression of PLG activators by
HUVECs. Moreover, leptospires endowed with PLG or PLA promoted transcriptional upregulationmatrix metalloprotease 9
(MMP-9). Serum samples from patients with confirmed leptospirosis showed higher levels of PLG activators and total MMP-9
than serum samples from normal (healthy) subjects. The highest level of PLG activators and total MMP-9 was detected with mi-
croscopic agglutination test (MAT)-negative serum samples, suggesting that this proteolytic activity stimulation occurs at the
early stage of the disease. Furthermore, a gelatin zymography profile obtained for MMPs with serum samples from patients with
leptospirosis appears to be specific to leptospiral infection because serum samples from patients with unrelated infectious dis-
eases produced no similar degradation bands. Altogether, the data suggest that the Leptospira-associated PLG or PLAmight rep-
resent a mechanism that contributes to bacterial penetration of endothelial cells through an activation cascade of events that
enhances the proteolytic capability of the organism. To our knowledge, this is the first proteolytic activity associated with lepto-
spiral pathogenesis described to date.
Leptospira interrogans is the causal agent of leptospirosis, a ne-glected zoonotic infectious disease of human and veterinary
concern. The transmission of leptospirosis is associated with ex-
posure of individuals to wild or farm animals (1). In urban set-
tings, leptospirosis became a major health problem due to the lack
of adequate sanitation measurements and the large population of
urban rodent reservoirs that contaminate the environment
through their urine (2). Although the leptospiral genome, func-
tional genomics, and host-pathogen interactions are being ac-
tively investigated by many research groups, the molecular aspects
of Leptospira virulence and pathogenesis and the origin of physi-
ological leptospirosis symptoms and severity of disease remain to
be understood (3–9).
L. interrogans has the capacity to disseminate rapidly, causing
systemic infection after skin penetration. Indeed, the rapid trans-
migration of polarized MDCK cell monolayers by virulent lepto-
spires has been reported (10), yet, the mechanisms involved in
such transmigration and dissemination were not understood (10).
The bacterial interaction with the host’s fibrinolytic system by
surface plasminogen (PLG) capture and/or PLG activation to
plasmin (PLA) has been suggested to be a feature that significantly
contributes to the virulence of several pathogens by facilitating
penetration and invasion (11). It has been shown that the coating
of Borrelia burgdorferi with PLA resulted in enhanced penetration
of endothelial cell monolayers (12). We first described the inter-
action of Leptospira with the PLG/PLA system and some possible
implications for pathogenesis (13). We demonstrated that lepto-
spires interact with PLG and can acquire PLA activity associated
with the surface without interfering in cell growth and viability,
which occur through multiple receptors (13–17). Although non-
virulent leptospires can interact with PLG, there seems to be a
correlation between the efficiency of PLG capture and virulence,
suggesting a role in virulence and infection. In fact, PLG receptors
seem to be differentially expressed in virulent strains.
In the present study, we focused on elucidating possible mech-
anisms involved when Leptospira cells associated with proteolytic
activity are in contact with human cells. We show that PLA gen-
eration on the surface of leptospires facilitates the bacterial trans-
migration across the human endothelial cell barrier compared
with leptospires lacking this proteolytic activity. We also show that
the interaction with mammalian cells promoted an upregulation
of PLG activators, thus increasing PLA generation on the bacterial
surface. Furthermore, we describe how the interaction of PLA-
associated Leptospira cells with human monolayer cells results in
an upregulation of matrix metalloproteases (MMPs) from human
umbilical vein endothelial cells (HUVECs). Moreover, we dem-
onstrate that serum samples from patients with confirmed lepto-
spirosis present different circulating amounts of PLG activators
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and MMPs than those from normal (healthy) individuals. Our
data provide the first evidence of mechanisms involved during
Leptospira-mammalian cell interactions that would contribute to
tissue penetration and rapid bacterial dissemination.
MATERIALS AND METHODS
Bacterial isolates and culture conditions. The virulent strain of L. inter-
rogans serovar Kennewicki strain Pomona Fromm (strain LPF) was iso-
lated from swine in the United States by the Salsbury/Solvay Laboratories.
The strain is routinely cultured by iterative passages in Golden Syrian
hamsters for maintenance of virulence. Recently weaned hamsters were
intraperitoneally infected with 500l containing approximately 1.0 104
virulent leptospires. The animals were sacrificed after appearance of
symptoms, such as loss of weight and mobility (approximately 5 days
postinfection). The kidney and liver were removed and macerated, and
the organ-derived leptospires were cultured at 28°C in modified Eling-
hausen-McCullough-Johnson-Harris (EMJH) medium supplemented
with 10% Leptospira enrichment EMJH medium (BD, Difco).
Human serum sample collection. Serum samples from patients with
confirmed leptospirosis were obtained from the collection of Instituto
Adolfo Lutz, São Paulo, Brazil; serum samples from patients with unre-
lated infectious diseases were obtained from the collections of the Labo-
ratorio de Imunoepidemiologia, SUCEN, São Paulo, Brazil, the Labora-
torio de Protozoologia, IMT/USP, São Paulo, Brazil (sera from patients
with Chagas’ disease), Laboratorio de Virologia, IMT/USP, São Paulo,
Brazil (sera from patients with human immunodeficiency virus [HIV]
infection and dengue), and the Nucleo de Estudos em Malária, SUCEN/
IMT/USP, São Paulo, Brazil (sera from patients with malaria). Normal
human sera were obtained from healthy donors with no reported lepto-
spirosis history.
MAT. The microscopic agglutination test (MAT) of the serum sam-
ples was performed according to Faine et al. (2). In brief, an array of
serovars of Leptospira spp. as antigens were employed: Australis, Autum-
nalis, Bataviae, Canicola, Castellonis, Celledoni, Copenhageni, Cynopteri,
Djasiman, Grippotyphosa, Hardjo, Hebdomadis, Icterohaemorrhagiae,
Javanica, Panama, Patoc, Pomona, Pyrogenes, Sejroe, Shermani,
Tarassovi, and Wolffi. All strains were maintained in EMJH liquid me-
dium (Difco) supplemented with 10% rabbit serum at 28°C. A laboratory-
confirmed case of leptospirosis was defined by the demonstration of a
4-fold microagglutination titer rise between paired serum samples. The
probable predominant serovar was considered the titer that was the high-
est sample dilution with 50% agglutination. The MAT was considered
negative when the titer was below 1:100. In addition to the MAT-negative
and MAT-positive samples from individuals with laboratory and clinical
confirmations of leptospirosis, we employed sera from normal, healthy
donors without a known history of leptospirosis and a confirmed negative
MAT.
Endothelial cell extraction and cultivation. The HUVECs were ob-
tained by collagenase digestion of umbilical veins as detailed by Jaffe et al.
(18). The cells were cultured in RPMI 1640 medium (Cultilab) supple-
mented with 10% fetal bovine sera (FBS) (Cultilab), 45 g/ml heparin
(Roche), 1 mM sodium pyruvate (Spectrum Chemical), 2 mM L-glu-
tamine (Sigma), 100 IU penicillin (Cultilab), 100 g/ml streptomycin
(Cultilab), 50M 2-mercaptoethanol (Pharmacia Biotech), 25g/ml en-
dothelial growth factor (Sigma), and 0.75% mouse brain extract, as a
supplement of growth factor (19). The latter was prepared by homogeni-
zation of approximately 5 g of mouse brain in 5 ml of RPMI medium, as
described by Maciag et al. (20). Cells were maintained at 37°C in a humid-
ified 5% CO2 incubator. Confluent HUVECs were passaged with 0.25%
trypsin and 0.02% EDTA (Cultilab) and seeded in appropriate culture
plates. First-passage confluent HUVECs were used in all experiments.
Leptospiral transmigration across HUVEC monolayers. Polycar-
bonate membrane (5-m) Transwell chambers of 6.5 mm (Corning)
were prepared with 100 l/well 4% gelatin. First-passage HUVECs
(15,000/well) were seeded over the gelatin layer and incubated with 1.5 ml
RPMI complete culture medium until total confluence of the monolayer
was reached (approximately 24 h). L. interrogans serovar Pomona cells
(5  108/sample) were treated with 50 g PLG (Calbiochem) in 200 l
low-salt phosphate-buffered saline (lsPBS) (PBS with 50 mM NaCl) for
1.5 h, followed by addition of 5 U urokinase-type uroplasminogen activa-
tor (uPA) (Sigma) for 1 h at 37°C. As controls, samples were treated with
only PLG or uPA or with no additions (PBS). After three washes with
lsPBS, each sample was resuspended in 200 l RPMI complete culture
medium lacking FBS, and 100 l of the bacterial suspension was added
over the HUVECs together with 100 l culture medium in the upper
chamber. Four hundred microliters of culture medium was added to the
lower chamber. After 4 h of incubation at 37°C in a 5% CO2 atmosphere,
the lower chamber content was harvested and leptospires were separated
by centrifugation at 10,000 g. The bacterial cells were resuspended in 1
ml lsPBS and counted in a Petroff-Hausser chamber under dark-field
microscopy. Three independent counts of all 25 squares were performed
by sample, and the number of leptospires was determined as total counted
cells 50,000 dilution.
Leptospiral HUVEC activation. HUVECs were seeded (15,000 cells/
well) onto cell culture microplates (96 wells) and incubated until they
reached total adherence for 16 h at 37°C in a 5% CO2 atmosphere. L.
interrogans serovar Pomona strain LPF (5 108/sample) was treated with
50g PLG (in 200l lsPBS) for 1.5 h, followed by addition of 5 U uPA and
incubation for 1 h at 37°C. Controls were treated without uPA, PLG, or
both PLG and uPA. After three washings with lsPBS, each sample was
resuspended in 500 l RPMI medium. The bacterial suspensions (100
l/well plus 100 l/well RPMI) were transferred to the microplates con-
taining the HUVECs previously washed with PBS for the removal of the
remaining FBS. As controls, HUVECs were incubated only with RPMI
medium lacking the bacteria. After 6 or 24 h of incubation at 37°C, the
media were collected, centrifuged for removal of cells and bacteria, and
frozen in aliquots at80°C until use.
Quantification of PLG activators.Human serum samples were quan-
tified as uPA and tPA (tissue-type plasminogen activator) by using com-
mercial kits based on the capture enzyme-linked immunosorbent assay
(ELISA) (AssayMax human urokinase and AssayMax human tissue-type
plasminogen activator from Assaypro). The protocols were performed as
recommended by the manufacturer.
Urokinase chromogenic activity assay. Human serum samples were
subjected to a uPA chromogenic activity direct assay (Assaypro) accord-
ing to the instructions provided by the manufacturer. The samples were
diluted 5 times prior to the analysis.
Zymography. Eight percent SDS-PAGE gel was copolymerized with
0.1% (mass/vol) gelatin (Difco) or type I human collagen (Sigma). Non-
denaturing 5 concentrated gel application solution (250 mM Tris-HCl
[pH 6.8], 2% [wt/v] SDS, 0.1 g/ml bromophenol blue, 10% [vol/vol]
glycerol) was added to the samples without a heating step. The samples
were loaded, and after running, the gels were washed twice for 15 min with
2.5% (vol/vol) Triton X-100 in 50 mM Tris-HCl (pH 8.4), followed by
two washes of 5 min in 50 mM Tris-HCl (pH 8.4). The gels were incubated
overnight (18 h) at 37°C in activation solution (50 mM Tris-HCl [pH
8.4], 5 mM CaCl2, 1 M ZnCl2) and then stained with Coomassie blue
(0.25% Coomassie blue R, 45% [vol/vol] methanol, 10% [vol/vol] glacial
acetic acid). The excess stain was removed by destaining solution (45%
[vol/vol] methanol, 10% [vol/vol] glacial acetic acid) until adequate visu-
alization of the degradation regions had been achieved. Control experi-
ments were performed with activation solution lacking CaCl2 and ZnCl2
or with 25 mM EDTA added to the activation solution.
For experiments with human sera, samples were diluted 20 times, and
10 l was applied per well. The sera were selected randomly from our
collection, independently of the MAT titer and serovar(s) involved. For
zymography of the cell culture supernatants, 20 l of the samples was
applied to each gel well. Culture supernatants from HT1080 cells (human
fibrosarcoma cell line) were employed as the positive control for pro-
MMP-2 and pro-MMP-9 degradation activity.
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2D gels for zymography andMS. For two-dimensional (2D) gel elec-
trophoresis, immobilized pH gradient (IPG) strips (GE Healthcare) (7
cm; pH 3 to 10) were rehydrated with 8l human serum samples (normal,
MAT negative, or MAT positive) diluted in 117 l of solution containing
9 M urea, 4% (mass/vol) CHAPS {3-[(3-cholamidopropyl)-dimethylam-
monio]-1-propanesulfonate}, 0.05% (vol/vol) Triton X-100, and bro-
mophenol blue. The strips were then subjected to isoelectric focalization,
equilibration, 8% SDS-PAGE, and preparation of the selected spots for
mass spectrometry (MS) as previously described (21). The only modifica-
tion was the exclusion of dithiothreitol (DTT) and iodoacetamide (IAA)
from the equilibration steps. The gels were performed in duplicates: one
subjected to zymography, as described above, and the other subjected to
Coomassie blue staining. The experiment was performed three times with
similar results.
Metalloprotease activity test.MMP-2 and MMP-9 were quantified by
specific activity assay systems (GE Healthcare), as recommended by the
manufacturer. When total (proenzymes and active enzymes) enzymes
were quantified, p-aminophenylmercuric acetate (APMA) was employed
with the samples. Serum samples were diluted 20 and 50 times for MMP-9
and MMP-2 determinations, respectively. Cell culture supernatants were
analyzed without dilutions.
Real-time PCR. Total RNA from the HUVECs after activation by lep-
tospiral contact was extracted using the RNAspin minikit (GE Health-
care), as recommended by the manufacturer. The RNA was quantitated by
spectrophotometry using a NanoDrop spectrophotometer (Thermo).
The cDNA was synthesized using 1,000 ng total RNA, the SuperScript III
reverse transcriptase kit (Invitrogen), and oligo(dT) primers, according to
standard protocols. The resulting cDNA was used for quantitative PCR
using TaqMan gene expression master mix (Applied Biosystems) and
TaqMan gene expression assays (Applied Biosystems) in a 7300 real-time
PCR system (Applied Biosystems). The genes evaluated were the human
MMP-9, uPA, tPA, and-actin (ACTB) genes (Applied Biosystems) (cat-
alog no. hs00957555_m1, hs01547050, hs00263492, and 4333762T, re-
spectively). ACTB was employed as constitutive control. Reaction condi-
tions were as described in the TaqMan gene expression master mix with 50
ng of cDNA in a total volume of 20 l, and the cycling protocol was as
follows: 50°C for 2 min, 95°C for 10 min, and 40 cycles of 95°C for 15 s and
60°C for 60 s. Each reaction was performed in triplicate, and the cycle
threshold (CT) values were calculated using 7300 System SDS Relative
Quantification Study software (Applied Biosystems). The relative expres-
sion ratio was calculated by the comparative 2CT method (22) using
ACTB as a constitutive control, and with 6 h of incubation time of the
RPMI sample (HUVECs) incubated without leptospires as the calibrator.
The range for target genes’ relative expression (maximum and minimum)
was calculated by 2CT with CT  s and CT  s, where s is the
standard deviation of the CT value.
Ethics statement. All animal studies were approved by the Ethics
Committee of the Instituto Butantan, São Paulo, SP, Brazil, under proto-
col no. 798/11. The Committee in Animal Research in Instituto Butantan
adopts the guidelines of the Brazilian College of Animal Experimentation.
The use of HUVECs for experimentation is approved by the Ethics Com-
mittee of Universidade Federal de São Paulo (UNIFESP), under protocol
no. 0664/05. Serum samples from patients with confirmed leptospirosis
and serum samples from patients with unrelated infectious diseases were
obtained from a serum collection, were rendered anonymous, and were
donated to be used for research purposes only. Written informed consent
was given by healthy blood donors.
RESULTS
Leptospiral transmigration throughHUVECmonolayers is en-
hanced by PLA. To evaluate whether PLA generation on the sur-
face of leptospires affects bacterial tissue penetration, virulent
low-passage-number L. interrogans serovar Pomona strain LPF
was used to infect primary cultures of HUVEC monolayers in
Transwell chambers. The results show that when the organisms
were treated with PLG or PLG plus uPA, the leptospires migrated
to the lower chamber across the cell monolayers more efficiently
than the control (PBS) leptospires (Fig. 1). The fastest migration
of leptospires through the monolayer was achieved when the bac-
teria generated PLA on their surface compared to the ones treated
only with PLG.
HUVEC activation by leptospires. In our previous work, we
have shown that leptospires do not have the capacity to convert
PLG to active PLA and are dependent on the host’s fibrinolytic
activation system (13). As leptospires treated with PLG but lacking
its activator showed higher migration activity across the cellular
barrier compared to PBS-treated control bacteria (Fig. 1), we
speculated whether leptospires could also promote upregulation
of PLG activators when in contact with HUVECs. Endothelial cells
were incubated with leptospires, and the total RNA of the cells was
extracted, followed by cDNA synthesis and real-time PCR evalu-
ation. HUVECs were tested for uPA and tPA PLG activator tran-
scription; the ACTB gene was used as the endogenous constitutive
control for the normalization of both activators levels. The data
obtained indicate that leptospires in contact with HUVECs pro-
moted on these cells an upregulation at the transcriptional level of
both PLG activators compared to cells not exposed to the bacteria
(treated with RPMI only) (Fig. 2A and B). The stimulation of the
uPA transcription was clearly observed after 24 h of HUVEC-
leptospire incubation; the transcription stimulation was higher
when PLG was present, but the strongest induction of uPA and
tPA transcriptional levels was achieved with PLA-associated lep-
tospires (more than 10 times for uPA and 2 times for tPA) (Fig. 2A
and B). A negligible increase in the transcription was observed
FIG 1 Penetration of HUVEC monolayers by leptospires. L. interrogans sero-
var Pomona strain LP was treated with PLG, PLG plus uPA, or only PBS. The
HUVEC monolayers previously seeded above the Transwell chamber polycar-
bonate membrane were inoculated with the leptospires (2.5 108). After 4 h,
the leptospires present in the lower chamber were recovered and counted by
dark-field microscopy. The bars represent the medians standard deviations
of two independent counts of each experimental duplicate. The data are rep-
resentative of three independent experiments. *, P	 0.0025; **, P	 0.03.
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upon 6 h of HUVEC-organism incubation for both activators.
The control cells (endothelial cells incubated with RPMI only)
produced insignificant differences in the levels of both PLG acti-
vators.
MMP secretion by HUVECs incubated with leptospires. It
has been proposed that PLA generated from PLG is an activator of
pro-MMPs (23). The PLA generated in the spirochete B. burgdor-
feri was shown to activate pro-MMP-9 in human cells (24). We
thus set up to investigate whether the PLA-generated activity on
leptospires was capable of promoting the activation or release of
MMPs by HUVECs coincubated in vitro with leptospires plus
the PLG/PLA proteolytic system. Gelatin zymography assays of
the cell culture supernatants were analyzed after incubation of
HUVEC-PLA-associated leptospires and controls for 6 and 24 h.
HT1080 cell culture medium was employed as a control for con-
stitutive secretion of pro-MMP-2 (72 kDa) and pro-MMP-9
(92 kDa). As shown in Fig. 3, protein degradation bands with
molecular masses similar to that of pro-MMP-2 activity upon gel-
atin substrate were visible on all samples, including both controls
lacking leptospires and samples incubated with treated or un-
treated leptospires for 6 or 24 h (Fig. 3). Supernatants from 24 h of
incubation show protein degradation bands with a molecular
mass similar to that of pro-MMP-9 and active MMP-2 (66 kDa)
in all samples. The white band with a molecular mass comparable
to that of active MMP-9 (78 kDa) became visible, although
weak, in the samples from HUVECs incubated for 24 h with lep-
tospires, treated or untreated, and was absent in the control with-
out bacteria (Fig. 3). Complementary control experiments were
FIG2 L. interrogans upregulates the transcription of PLG activators from HUVECs. Primary cultures of HUVECs were incubated for 6 or 24 h with L. interrogans
serovar Pomona without treatment (PBS) or were treated with PLG, uPA, or PLG plus uPA. As a negative control, HUVECs were incubated only with the culture
medium, without bacteria (RPMI). The HUVECs’ total RNA was extracted, and with the cDNAs as the template, real-time PCR was employed forCT analysis and
fold change calculation relative to the HUVECs incubated in the absence of bacteria for 6 h and 24 h. In panels A and B are the data obtained for uPA and tPA,
respectively. The bars represent the range of the relative fold changes from triplicates, calculated as described in Materials and Methods. The data are represen-
tative of two independent experiments.
FIG 3 Zymography analysis of MMPs released into the culture of HUVECs in
response to Leptospira. Primary cultures of HUVECs were incubated for 6 or
24 h with L. interrogans serovar Pomona without treatment (PBS) or were
treated with PLG, uPA, or PLG plus uPA. As a negative control, HUVECs were
incubated only with the culture medium, without bacteria (HUVECs).
HT1080 supernatants were employed as positive controls for pro-MMP-2
(72 kDa) and pro-MMP-9 (92 kDa) constitutive release. The samples were
separated by 8% SDS-PAGE with gel copolymerized with 0.1% gelatin. After
overnight incubation in activation solution, the gels were stained with Coo-
massie blue. The clear bands represent the regions where the gelatin substrate
was degraded. The molecular masses of 92 kDa, 72 kDa, and 60 kDa,
which correspond to pro-MMP-9, pro-MMP-2, and active MMP-2, respec-
tively, are depicted.
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carried out by employing the activation solution lacking CaCl2
and ZnCl2 or with the addition of 25 mM EDTA. Under these
conditions, no degradation bands were observed (data not
shown), demonstrating that the proteolytic activity was due to
metal-dependent activity of the MMPs.
Thus, we decided to evaluate MMPs’ activity on the cell
culture supernatants, from the same systems described above,
by using an ELISA based on capture. The results show that
there was no increase in either active or total MMP-9 after 6 h
of incubation. However, while there is a tendency toward an
increase in total MMP-9 (Fig. 4A) with all of the supernatants
from HUVECs incubated with leptospires, PLG treated for 24 h
or not, the values were not statistically significant (P 
 0.05).
Active MMP-9 remained unaffected in the same supernatants
after 24 h of incubation (P 
 0.05) (Fig. 4A). Total or active
MMP-2 showed no significant differences after 6 or 24 h of
incubation in the presence or absence of leptospires, either
PLG treated or not (P 
 0.05) (Fig. 4B). To assess whether the
higher release of total MMP-9 by HUVECs exposed to the bac-
teria seen in Fig. 3 was due to an upregulation of this enzyme,
we performed real-time PCR using total HUVEC cDNA as the
template and specific primers to MMP-9. The results indicate
that PLA-associated Leptospira, bacteria plus PLG, or bacteria
plus uPA promoted upregulation of MMP-9 from HUVECs,
the highest transcriptional level being observed with PLA-
coated leptospires incubated for 24 h (Fig. 4C).
Detection of PLG activators on serum samples frompatients
with confirmed leptospirosis.L. interrogansorganisms can incor-
porate PLG onto their surface, and PLA is generated in the pres-
ence of exogenous PLG activators (13). Therefore, we decided to
investigate serum samples from patients with confirmed leptospi-
rosis for the presence of uPA and tPA PLG activators using com-
mercial kits based on capture ELISA. Serum samples at the begin-
ning (MAT-negative) or convalescent (MAT positive) phase of
leptospirosis were employed. Samples from healthy donors were
employed for a comparative purpose. The results reveal that both
uPA and tPA activators are present in higher quantities in serum
samples from patients with confirmed leptospirosis than in sam-
ples from healthy donors (Fig. 5A and B). The highest levels of
both activators were detected at the early phase of disease (MAT
negative), suggesting that the bacteria induce the release of both
uPA and tPA activators from the hosts during the first days of the
illness. Very low levels of activators were detected in sera from
healthy donors, particularly in the case of uPA (Fig. 5A). To in-
vestigate whether the increase of activators in these samples was
not only at the concentration level but also was represented by
activity, we measured the uPA specific activity of each serum sam-
ple employed. The results show that an increase in uPA activity
was observed with leptospirosis patient serum samples compared
to samples from normal, healthy donors (Fig. 5C). In all of the
experiments, statistically significant values were calculated by
comparing MAT-negative and MAT-positive samples with the
control sera (normal) (*, P	 0.006; **, P	 0.130; ***, P	 0.06).
Zymographyprofile analysis of normal and leptospirosis hu-
man serum samples. The interaction of leptospires with the PLG
activation system, PLG or PLG plus uPA (25), has the capacity to
promote upregulation of MMP-9 from human endothelial cells
(Fig. 4). These results prompted us to investigate whether the
MMPs’ activity and expression are altered during natural human
leptospirosis by performing zymography analysis. A human se-
rum sample (0.5l) was applied to SDS-PAGE gel copolymerized
with gelatin as a substrate for gelatinase (MMP) activity proteases.
After incubation in activation solution, the gels were Coomassie
blue stained; the white bands represent regions where the sub-
strate was degraded. The gelatin zymogram profile obtained for
MAT-negative and MAT-positive serum samples from patients
with confirmed leptospirosis and from healthy individuals (nor-
mal) is presented in Fig. 6A. The arrows indicate the discrepancy
in visual intensity between the serum samples from healthy sub-
jects and those from patients with leptospirosis, corresponding to
the molecular mass of approximately 90 kDa (Fig. 6A), probably
representing pro-MMP-9, reflecting higher degradation activity
during the disease. In addition, another region of substrate degra-
dation is observed above the arrows in samples from patients with
confirmed leptospirosis (Fig. 6A, indicated by asterisks).We fur-
ther confirmed these activity data by performing the same exper-
iment but with collagen type I zymography. The results depicted
in Fig. 6B revealed elevated levels of degradation in the same re-
gion (90 kDa) with the serum samples from patients with lep-
tospirosis compared with the serum samples from normal,
healthy donors. Additional control experiments were performed
using the activation solution lacking CaCl2 and ZnCl2 or with the
addition of 25 mM EDTA. Under these conditions, no degrada-
tion bands were observed (data not shown), indicating that the
proteolytic activity was due to metal-dependent activity of the
MMPs.
In an attempt to identity the MMPs responsible for the ob-
served enhanced activity, we performed 2D gel analysis of human
serum samples. 2D gel analyses were performed in duplicates,
with one of the gels Coomassie blue stained and the other sub-
jected to zymography (Fig. 6C). Similar to the data with the 1D gel,
pronounced degradation activity was shown in gelatin 2D zymog-
raphy in the same region (90 kDa) and above in confirmed-
leptospirosis samples, both MAT negative and MAT positive, as
denoted by arrows and asterisks in Fig. 6C. Almost no degradation
activity was seen in normal serum samples (Fig. 6C). Coomassie
blue protein spots were not visualized in the region where degra-
dation activity was detected in zymography, possibly due to the
higher sensitivity of the latter compared to protein-colored stain-
ing. Thus, by overlapping the gels, we excised 9 samples from each
condition (in the regions corresponding to the white bands in the
zymogram) from the Coomassie blue-stained gels and samples
were prepared for MS. Although some peptides were detected af-
ter MS, protein identification was inconclusive, presumably as a
result of the limited amounts of MMPs present or the interference
of contaminant proteins in human serum.
To further validate the data obtained by zymography experi-
ments, we also performed MMP activity assays and measured total
and active MMP-9 in all serum samples. The results reveal an
elevated level of total MMP-9 at the early stage of the disease
(MAT-negative serum samples), while this level tends to reach
normal values during the convalescent phase (MAT positive) (Fig.
7). In contrast, the amount of active MMP-9 was very low, and
similar values were detected in normal and leptospirosis serum
samples. The total MMP-9 concentration level observed among
MAT-negative samples corresponds to approximately 2.5 times
the normal samples’ mean concentration (Fig. 7).
Zymography analysis of serum samples from patients with
leptospirosis and those with unrelated infectious diseases. In
view of the presence of gelatin/collagen-enhanced degradation ac-
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FIG 4 MMP-9 and MMP-2 levels released into the culture of HUVECs in response to Leptospira. Primary cultures of HUVECs were incubated for 6 or 24 h with
L. interrogans serovar Pomona without treatment (PBS) or were treated with PLG, uPA, or PLG plus uPA. As a negative control, HUVECs were incubated only
with the culture medium, without bacteria (RPMI). The cleared cell culture supernatants were evaluated for MMP-9 (A) or MMP-2 (B) activity by commercial
ELISA kit. Total activities of MMP-9 and MMP-2 were achieved by APMA (Materials and Methods) activation of the pro-MMPs. The bars represent the medians
of duplicates from two independent experiments  standard deviations. (C) The cDNA obtained by extraction of the HUVECs’ total RNA was subjected to
real-time evaluation for MMP-9 gene transcription. The data were normalized according to the ACTB constitutive control. The bars represent the range of the
relative fold changes from triplicates, calculated as described in Materials and Methods. The data are representative of two independent experiments.
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tivity in serum samples from patients with leptospirosis (Fig. 6) in
concert with the elevated levels of total MMP-9 detected in MAT-
negative serum samples (Fig. 7), we decided to investigate whether
this elevated activity was restricted to leptospirosis or common to
other infectious diseases. We performed gelatin zymography and
compared both phases of leptospirosis with serum samples from
patients with dengue, malaria, HIV, and Chagas disease (Fig. 8).
Our data show a strong gelatinase activity present in serum sam-
ples from patients with both phases of leptospirosis, probably rep-
resenting pro-MMP-9 (indicated by arrows), in contrasting to the
absence of degradation bands in all serum samples from patients
with the other infectious diseases tested. The zymography profiles
obtained for dengue, malaria, and Chagas are similar to the ones
observed with the normal human serum samples used as controls
(Fig. 6). HIV samples resulted in a different profile where some
other degradation bands lower than the 92-kDa molecular mass
are presented.
DISCUSSION
Previous work in our laboratory has described the ability of Lep-
tospira to capture PLG on the surface and to generate PLA in the
presence of exogenous uPA activator (13). Several outer mem-
brane leptospiral proteins with expected roles in pathogenesis and
virulence have been identified as PLG-binding receptors, suggest-
ing that the interaction with the fibrinolytic system might be im-
portant during leptospirosis (14–17, 26). Indeed, the association
of PLA with Leptospira renders the bacteria with proteolytic activ-
ity capable of degrading ECM components (13), which in turn,
may help bacterial penetration and dissemination. Moreover,
PLA-coated leptospires have also shown the ability to degrade IgG
and C3b, which could facilitate bacterial immune evasion (27).
We focused the present study on the analysis of the effects of
leptospiral PLG binding and PLA generation on the dissemination
and activation of endothelial cells. We show that Leptospira cells
with surface-associated PLG or an active PLA coating have an
enhanced transmigration activity through endothelial cell barriers
compared to the leptospires’ basal proteolytic activity (Fig. 1). In
fact, proteinase/gelatinase activity has been reported in many
strains of Leptospira (28, 29). It has been shown that cells of the
Lyme disease spirochete B. burgdorferi coated with PLA migrate
faster through cell monolayers than the bacteria without the pro-
teolytic activity (12). Although B. burgdorferi enters the host after
tick bite, Coleman and colleagues (12) discussed that PLG could
be bound just before bacterial penetration and converted to PLA
by activators present in the inflammatory skin focus. As men-
tioned before, PLA-coated Leptospira cells have the capacity to
degrade ECM components in vitro (13). The faster transmigration
of cellular barrier observed with Leptospira cells endowed with the
PLG/PLA system is most probably due to the PLA proteolytic
activity conferred to the bacteria. Moreover, the doubling time for
pathogenic leptospires is 14 to 18 h (30) and the presence of PLG/
PLA reagents does not impair cell division because there is no
modification in culture growth monitored for 48 h (M. L. Vieira
and A. L. T. O. Nascimento, unpublished results). The fact that we
have employed a PLG concentration close to the physiological
condition (31) suggests that our data might have implications
during infection. Indeed, the PLG/PLA binding has been de-
scribed to facilitate the keratinocyte invasion by Streptococcus pyo-
genes (32). Furthermore, it has been reported that the fungal
pathogen Cryptococcus neoformans coated with PLG promotes ex-
tracellular matrix (ECM) invasion (33). Surprisingly, the cellular
transmigration efficiency of leptospires treated only with PLG and
lacking uPA was higher than that in the untreated control. Previ-
ous studies in our laboratory have indicated that Leptospira cells
do not have an endogenous mechanism for PLG activation (13).
We therefore hypothesized that the bacterial contact could stim-
ulate the expression and/or secretion of PLG activators by the
HUVECs, transforming the bound PLG into enzymatically active
PLA. The increased level of uPA and tPA transcripts revealed that
the expression of both activators is, in fact, upregulated when the
HUVECs are coincubated with the leptospires. Intriguingly, the
upregulation of the activators was negligible after 6 h of incuba-
FIG 5 Measurement of PLG activators and uPA activity in serum samples
from normal, healthy donors and patients with confirmed leptospirosis.
Paired serum samples from individuals with confirmed leptospirosis in the
initial (MAT-negative) or convalescent (MAT-positive) phase or serum sam-
ples from healthy donors (Normal) were quantified for the presence of uPA
(A) or tPA (B) by specific capture ELISA kits. The quantification was based on
uPA and tPA standard curves. The symbols represent the individual dosage of
each sample, and the horizontal bars represent the medium. In panel C are
shown the measurements of uPA activity by specific activity test. Plotted in the
graphic is the activity determinate of each serum sample. The horizontal bars
represent the means of the serum samples for each group. Statistically signifi-
cant values were calculated by comparing MAT-negative and MAT-positive
samples with the control sera (normal): *, P	 0.006; **, P	 0.130; ***, P	
0.06.
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tion (Fig. 2), while the enhanced penetration was already detected
after 4 h of treatment (Fig. 1). Thus, it is possible that Leptospira-
associated PLG was activated in the early hours of incubation by
releasing PLG activators from the endothelial cells. In fact, it is
documented that endothelial cells contain several distinct popu-
lations of regulated secretory organelles, including the tPA organ-
elle (34), and that the secretion of this activator is induced during
injury or the inflammation process (35). Dengue virus infection
FIG 6 Zymography profile of samples form healthy donors and patients with leptospirosis. Human serum samples from healthy donors (Normal) and paired
serum samples from patients with leptospirosis at the early (MAT-negative) and convalescent (MAT-positive) phases of the disease were separated by 8%
SDS-PAGE with gel copolymerized with 0.1% gelatin (A) or type I collagen (B). After incubation in activation solution, the gels were Coomassie blue stained. The
white bands represent the regions where the substrate was degraded. The arrows and asterisks indicate the regions with the most pronounced differences in
degradation between serum samples from patients with confirmed leptospirosis and normal human serum samples. Lanes: M, molecular mass marker; 1 to 9,
individual serum samples. (C) 2D gel analysis (7-cm IPG strips [pH 3 to 10]) of normal, MAT-negative, and MAT-positive human serum samples. Extensive
degradation regions are denoted by arrows and asterisks. Duplicates were Coomassie blue stained or subjected to gelatin zymography. The experiment was
performed three times with similar results.
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was also reported to stimulate the release of tPA from human
endothelial cells (36). Consequently, the higher availability of PLG
activators could elicit the activation of the leptospiral-bound PLG
to active enzyme, triggering PLA-mediated ECM proteolysis and
promoting an enhanced transmigration activity.
Interestingly, serum samples from patients with confirmed
leptospirosis have larger amounts of both PLG activators avail-
able in circulation compared to normal serum samples. We
were able to confirm that in the case of uPA, the activity in
serum samples from patients with leptospirosis is also elevated,
suggesting that there is no concomitant increase in uPA inhib-
itors, like PLG activator inhibitors PAI-1 and PAI-2. The fact
that higher PLG activator levels were detected in MAT-negative
serum samples suggests that this activation is elicited at the
beginning of the invasion process, thus increasing the PLA pro-
teolytic activity generation that would be important during the
leptospiral invasion.
MMPs are well known to be directly and actively involved in
the origin of pathology in some infections, as MMP expression can
be stimulated by many pathogens (24, 37, 38). Furthermore, PLA
can induce directly or indirectly MMP expression and is able to
activate MMPs by the proteolytic cleavage of the propeptide do-
mains that confer latency to the secreted pro-MMPs (24, 39–41).
It has been suggested that the spirochete B. burgdorferi promoted
an upregulation of MMPs mediating an activation cascade that is
started by PLA bound to the bacterial surface (24). The incubation
of leptospires with HUVECs stimulates an upregulation of
MMP-9 by endothelial cells, an activity that could contribute to
the disruption of ECM and endothelial tissues, favoring the pen-
etration and invasion of the bacteria. It is possible that this cascade
of events occurs during human leptospirosis infection because
elevated levels of circulating total MMP-9 were detected in serum
samples from patients with confirmed leptospirosis. Interestingly,
similar to the levels of PLG activators detected, the MMP-9 con-
centration was higher with MAT-negative serum samples, sug-
gesting that the cascade of proteolytic activity generation takes
place at the early onset of the illness. PLA generated on the surface
of bacteria seems to be associated with spirochete infection, such
as Lyme disease, relapsing fever, and leptospirosis, because unre-
lated infectious diseases appear to lack this activity. Further stud-
ies are needed to understand the effects of the high levels of MMPs
during human leptospirosis in addition to the facilitation of pen-
etration and invasion of tissues.
In conclusion, the present work shows that the interaction of L.
interrogans with the PLG and PLA fibrinolytic systems enhances
the migration of the bacteria through endothelial monolayer cells.
Moreover,Leptospira-bound PLG has the capacity to stimulate the
release and expression of PLG activators from endothelial cells,
thus promoting increased generation of PLA-coated leptospires.
Furthermore, this proteolytic system is capable of eliciting an up-
regulation of MMP-9 from HUVECs. Altogether, our results sug-
FIG 7 Total amount and enzymatic activity of MMP-9 from human serum
samples. Human serum samples from healthy donors (Normal) and serum
samples from patients with leptospirosis at the initial phase (MAT) and
convalescent phase (MAT) were quantified for total contents and enzymatic
activity of MMP-9. Total or enzymatic activity of MMP-9 was achieved by
APMA activation of the pro-MMP. Bars represent the means of the samples
(n 8) quantified in duplicates standard deviations. *, P	 0.02.
FIG 8 Comparison of zymography profiles from serum samples from patients with confirmed leptospirosis and other infectious diseases. In panel A are shown
serum samples from patients with leptospirosis at the initial phase (lanes 1 and 2) or convalescent phase (lanes 3 and 4) and sera from patients with unrelated
infectious diseases: dengue (lanes 5 to 7) and malaria (lanes 8 to 10). In panel B are shown results for samples from patients with HIV (lanes 5 to 7) and Chagas’
disease (lanes 8 to 10). The samples were separated by 8% SDS-PAGE with gel copolymerized with 0.1% gelatin, incubated in activation solution, and stained by
Coomassie blue. The clear bands represent the regions where the substrate was digested. The arrows indicate the regions with most pronounced difference in
degradation between samples from patients with leptospirosis and those from patients with other diseases.
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gest that leptospires associated with the fibrinolytic system can
trigger a cascade of proteolytic activity initiated by PLA generation
after the binding of PLG to the leptospiral surface. MMPs together
with PLA-associated Leptospiramay represent one possible mech-
anism that contributes to the invasion and the rapid dissemina-
tion of this organism.
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